Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
What Is the Current and Projected Market Size of the Multiomics Market Through 2034?
In the past few years, the multiomics market has seen significant expansion. The projected growth is from $3.27 billion in 2024 to $3.85 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 17.7%. Factors contributing to this growth during the historical period include an increase in biomedical research, greater government and private sector investment, a surge in chronic diseases, advancement in technology, and improved tools and software for data analysis.
In the coming years, the multiomics market size is projected to experience swift growth, escalating to$7.11 billion in 2029 with a compound annual growth rate (CAGR) of 16.6%. The anticipated growth during the forecast period can be ascribed to improvements in artificial intelligence and machine learning, wider clinical application, expansion of the biopharmaceutical industry, the rise of comprehensive multiomics platforms, and increased application in agricultural as well as environmental studies. Key trends during the forecast period encompass technological progression, the introduction of new commercial multiomics platforms, the implementation of spatially resolved multiomics analysis, its application in biopharmaceutical research and development, and its proliferation into clinical diagnostics.
Download a free sample to assess the report’s scope and structure:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15866&type=smp
What are the Fundamental Drivers and Innovations Shaping the Multiomics Market?
The burgeoning necessity for bespoke medical treatment is set to stimulate the expansion of the multiomics market. Bespoke medical treatment is a patient-centric medicinal method that individualizes healthcare options and therapies, taking into account their genetic, environmental, and lifestyle characteristics. This rise in bespoke medical treatment is attributed to technological progression, increased demand for precise therapies, and worldwide advances in healthcare. Multiomics aids bespoke medical treatment by contributing an in-depth comprehension of a patient’s genetic, molecular, and metabolic makeup, allowing health professionals to adjust treatments based on each patient’s unique attributes. For instance, data from the US-based non-profit organization, the Personalized Medicine Coalition, revealed that in February 2024, the FDA gave approval to 16 revolutionary bespoke therapies for patients with rare ailments in 2023, a significant increase from 6 in the previous year. Hence, the escalating demand for bespoke medical treatment is propelling the growth of the multiomics market.
How Is the Multiomics Market Segmented?
The multiomicsmarket covered in this report is segmented –
1) By Type: Single-Cell Multiomics; Bulk Multiomics
2) By Platform: Genomics; Transcriptomics; Proteomics; Metabolomics; Integrated Omics Platforms
3) By Application: Diagnostics; Drug Discovery And Development; Personalized Medicine; AgriGenomics; Other Applications
4) By End User: Academics And Research Organization; Pharmaceutical And Biotechnology Companies; Clinical research Organization; Other End-Users
Subsegments:
1) By Single-Cell Multiomics: Single-Cell Genomics; Single-Cell Transcriptomics; Single-Cell Epigenomics; Single-Cell Proteomics; Single-Cell Metabolomics
2) By Bulk Multiomics: Genomics; Transcriptomics; Epigenomics; Proteomics; Metabolomics
Request customized data on this market:
https://www.thebusinessresearchcompany.com/customise?id=15866&type=smp
Which Regions Are Driving the Next Phase of the Multiomics Market Growth?
North America was the largest region in the multiomics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the multiomics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
What Key Trends Are Shaping the Future of the Multiomics Market?
Leading firms in the multiomics market are spearheading the development of cutting-edge single-cell multiomics platforms. These platforms are designed to support scientists in conducting large-scale research without compromising the integrity of their samples. By merging diverse omics with artificial intelligence, these platforms provide an efficient way to sift through and make sense of intricate biological data using complex algorithms and machine learning approaches. A notable example of this progress took place in February 2023 when Becton, Dickinson, and Company, a prominent US medical device firm, unveiled the BD Rhapsody HT Xpress. This high-throughput single-cell multiomics platform is a revolutionary system that affords scientists the ability to isolate, barcode and scrutinize single cells at an elevated sample throughput rate. Notably, it can handle up to eight times more cells than older BD single-cell analyzers. The BD Rhapsody HT Xpress System is designed to prevent sample loss, providing the capability to examine multiple samples, and various cell sizes and types concurrently, which includes stem cells or cancer cells. This enhances the ability of researchers to glean more useful insights in a shorter timeframe.
View the full report here:
https://www.thebusinessresearchcompany.com/report/multiomics-global-market-report
How Is the Multiomics Market Defined and What Are Its Core Parameters?
Multiomics refers to the integration and analysis of multiple omics data types, such as genomics, transcriptomics, proteomics, metabolomics, and epigenomics to provide a more comprehensive understanding of biological systems. This technique improves understanding of complex diseases, biomarker identification, and precision medicine.
Purchase the full report and get a swift delivery:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15866
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Europe +44 7882 955267
Asia & Others +44 7882 955267 & +91 8897263534
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model